chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On 01/24/2021,  everything started spinning and I began vomiting. I had to lay down in bed and rest. On 03/23/2021, I had another episode of vertigo where I vomited profusely and my head kept spinning and I felt so dizzy. Ever since receiving my second dose, I've had severe vertigo episodes on the following dates: 04/16/2021, 06/16/2021, 07/03/2021, 09/20/2021, 09/23/2021, 10/05/2021, 10/12/2021, 10/15/2021, 10/16/2021, 10/17/2021, 10/22/2021, 10/23/2021, 10/25/2021, 11/05-06/2021, 11/17/2021, 11/30/2021, 12/11/2021, 12/30/2021, 01/09/2022, 01/16/2022, and 01/17/2022. I've seen so many specialists since these episodes from neurologist, ENT doctor, cardiologist and a physical therapist who tested me for hearing and balance. There hasn't been any conclusive results from any specialists in regards to a definitive diagnosis to my problem. I can't even properly travel around for work.
Patient was given FluMist (live vaccine) on 10/2/09 at the county health dept.  She complained of flu-like symptoms (no fever) and called and was seen at our clinic on 10/5/09.  In caution, we prescribed the chemoprophylaxis dose of oseltamivir (60 mg once daily for 10 days).  She has since completed the 10 days course of therapy and is doing well.  She had no further complications from the FluMist.
severe pain in multiple joints (knees, hips, hands and fingers)/severe pain/shoulders; severe pain in my back; severe pain/neck; severe pain in multiple joints (knees, hips, hands and fingers); It has made it difficult to walk and use my hands; It has made it difficult to walk and use my hands; tiredness; drowsiness; High blood glucose; This is a spontaneous report from a contactable consumer (patient).A 67-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EN6203), via an unspecified route of administration, administered in right arm on 23Feb2021 at 10:45 (at the age of 67 years) as dose 2, single for COVID-19 immunization.Medical history included ongoing type 1 diabetes mellitus from 14Feb1968 and ongoing osteoarthritis from May1995. Concomitant medications were none. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EN5318), via an unspecified route of administration, administered in right arm on 29Jan2021 at 15:30 (at the age of 67 years) as dose 1, single for COVID-19 immunization and experienced blood glucose increased. On an unspecified date in 2021 at 11:00, the patient experienced severe pain in multiple joints (knees, hips, hands and fingers), severe pain in her back and neck and shoulders, which has not gone away since her vaccination. It has made it difficult to walk and use her hands, also caused tiredness and drowsiness and on an unspecified date in 2021 at 04:00, the patient had High blood glucose. Events did not result in visit to emergency room or physician office. No relevant test performed. It is unknown if there are any predisposing factors, also no culture was performed. The outcome of event High blood glucose was unknown, and patient had not yet recovered from all other events.  No follow-up attempts are possible. No further information is expected.
This spontaneous report as received from a physician via a Company representative refers to a "less than a 1 year old" patient of unknown gender. Medical and concurrent conditions were not reported. On an unknown date, the patient was exposed through his/her grandparent was vaccinated with ZOSTAVAX (dose, strength, route and lot number were not reported). Secondary and concomitant therapies were not reported. The physician reported that after ZOSTAVAX was administered to a consumer, the consumer's "unvaccinated" grandchild developed a "significant" case of chickenpox. According to physician, the chickenpox resulted in "complications" for the grandchild. It was reported that the patient sought unspecified medical attention. At the time of the report, the patient's outcome was unknown. The physician considered that chickenpox and the chickenpox resulted in "complications" caused to the patient a significant disability or incapacity. It was noted that the physician attributed the child's chickenpox to the ZOSTAVAX administered to grandparent being around the "less than 1 year old" grandchild. The physician was now telling patient vaccinated with ZOSTAVAX to avoid contact with children less than a year old for "six weeks" after getting the shot. Additional information has been requested.
Patient received booster dose of Vaccine Pfizer with the lot # FG3527 and expiration date 02/2022 on 12/13/2021 and the vial of vaccine was stored in the fridge and should have been used before the date of 12/12/2021 , as a result the vail of vaccine was considered expired for one day, however patient has not experienced any side effect.
For almost a week now I've experienced  a slight hearing loss, seems to be in my right ear!! There is a constant slight numb like feeling in the right ear! At times out of no where there is a ringing sound in my ear!! This concerns me!! Other effects like soreness in the arm ,fatigue, and joint pain went away within a few days! I took tylenol for that!! I was told that you all could give me no answers!! I waited to see if this would pass!! I'm trying to see my MEDICAL PROFFESSIONAL about this issue!! I have questions! How long will this last and is this normal!! I've called  your hotlines, what's the use if they can't answer questions!! I'm a Substitute  Teacher,  this makes  me uncomfortable!! What should I do!!
Lump, left thigh, red and hard, about size of softball.  No fever. Warm to touch.  A little painful.  Advised to give Motrin and ice area.  No streaking.  Follow up if acting ill or see red streaks.
I became ill on 10/20, and on Friday, I had a really high fever. My doctor advised to go to the hospital ER. I was admitted Friday night and was there until 10/27. I was on IV antibiotics, and I was sent home with oral antibiotics. I had 2 different scans completed and blood tests that ruled that I have Acute Cholecystitis, so I have to have my gallbladder removed. I am meeting with the doctors and the removal will be within the next 5 weeks.
Information has been received from a registered nurse concerning a 71 year old white female patient with allergies to erythromycin and alprazolam (Xanax) who on Jul 08 2004 at  3:23 pm was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot 647636/0944N), intramuscularly in the right deltoid. Concomitant therapy included pimecrolimus (Elidel). There was no illness at the time of vaccination. On Jul 08 2004 at 3:23 pm the patient developed soreness and redness at the site per patient. The patient reportedly recovered on jul 09 2004. It was also reported that on Jul 09 2004 the patient experienced swelling and tenderness that was significant enough that she could not lift her arm. The pain persisted for three to four weeks. Unspecified medical attention was sought. No additional information is expected.
This spontaneous report was received from a medical assistant refers to a patient of unknown age who on 07-AUG-2014 the patient was vaccinated with an improperly stored dose of PROQUAD (lot #, expiration date and dose unspecified). No adverse events were reported. No further information was provided. This is one of several reports received from the same source. Additional information has been requested.
VACCINE EXPOSED OT TEMP OUTSIDE OF REC STORAGE RANGE. UNKNOWN VIABILITY/POTENCY PER MANUFACTURER.
Child developed combative behavior with labile emotions for two days then became feverish (>102), had myalgias, lethargy and fatigue on day 3 (12/6/2021).
Patient received a vaccine that was stored beyond the 30 days recommended in the refrigerated state. This event was reported to the manufacturer. The manufacturer tested the lot number in question. Data revealed that the vaccine administered did not maintain activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration. Healthcare facility consulted with the  Dept of Public Health and Environment and recommended repeating this dose in question. Patient was sent a letter to inform them of the need to repeat the dose in question. Healthcare is working with the Dept of Public Health and Environment on a compliance improvement plan and has been reinstated vaccination privileges.
Arm burning and hot; Arm stinging; itchy; hard arm; felt like my throat might of been a little swollen; Arm was swollen/puffy; Felt terrible; Tired; lethargic; Red arm; This spontaneous case was reported by a consumer and describes the occurrence of PHARYNGEAL SWELLING (felt like my throat might of been a little swollen), PERIPHERAL SWELLING (Arm was swollen/puffy), FEELING ABNORMAL (Felt terrible), SKIN BURNING SENSATION (Arm burning and hot) and PAIN (Arm stinging) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced PERIPHERAL SWELLING (Arm was swollen/puffy), FEELING ABNORMAL (Felt terrible), LETHARGY (lethargic), ERYTHEMA (Red arm) and FATIGUE (Tired). On 24-Jan-2021, the patient experienced PHARYNGEAL SWELLING (felt like my throat might of been a little swollen). On 30-Jan-2021, the patient experienced SKIN BURNING SENSATION (Arm burning and hot), PAIN (Arm stinging), PRURITUS (itchy) and INDURATION (hard arm). On 23-Jan-2021, FEELING ABNORMAL (Felt terrible) had resolved. On 27-Jan-2021, PHARYNGEAL SWELLING (felt like my throat might of been a little swollen) had resolved. At the time of the report, PERIPHERAL SWELLING (Arm was swollen/puffy), SKIN BURNING SENSATION (Arm burning and hot), PAIN (Arm stinging), LETHARGY (lethargic), ERYTHEMA (Red arm), PRURITUS (itchy), INDURATION (hard arm) and FATIGUE (Tired) outcome was unknown.            Concomitant medications were not provided.  Treatment medications included antihistamines for swelling and itching.   Most recent FOLLOW-UP information incorporated above includes: On 19-Apr-2021: No specific follow-up information recorded.
Tingling in the right arm and couldn't lay on it for three days; Tingling in the right arm and couldn't lay on it for three days; Chest also feels heavy; Bumps on neck area with rash; Arm turned purple at the injection site, itched, welt shaped in a band and felt feverish; Arm turned purple at the injection site, itched, welt shaped in a band and felt feverish; Arm turned purple at the injection site, itched, welt shaped in a band and felt feverish; Arm turned purple at the injection site, itched, welt shaped in a band and felt feverish; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling in the right arm and couldn't lay on it for three days), LIMB DISCOMFORT (Tingling in the right arm and couldn't lay on it for three days), CHEST DISCOMFORT (Chest also feels heavy), RASH PAPULAR (Bumps on neck area with rash) and VACCINATION SITE DISCOLOURATION (Arm turned purple at the injection site, itched, welt shaped in a band and felt feverish) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported.     On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PARAESTHESIA (Tingling in the right arm and couldn't lay on it for three days), LIMB DISCOMFORT (Tingling in the right arm and couldn't lay on it for three days), CHEST DISCOMFORT (Chest also feels heavy), RASH PAPULAR (Bumps on neck area with rash), VACCINATION SITE DISCOLOURATION (Arm turned purple at the injection site, itched, welt shaped in a band and felt feverish), VACCINATION SITE WARMTH (Arm turned purple at the injection site, itched, welt shaped in a band and felt feverish), VACCINATION SITE PRURITUS (Arm turned purple at the injection site, itched, welt shaped in a band and felt feverish) and VACCINATION SITE URTICARIA (Arm turned purple at the injection site, itched, welt shaped in a band and felt feverish). The patient was treated with ACETAMINOPHEN at a dose of 1 dosage form. At the time of the report, PARAESTHESIA (Tingling in the right arm and couldn't lay on it for three days), LIMB DISCOMFORT (Tingling in the right arm and couldn't lay on it for three days), CHEST DISCOMFORT (Chest also feels heavy), RASH PAPULAR (Bumps on neck area with rash), VACCINATION SITE DISCOLOURATION (Arm turned purple at the injection site, itched, welt shaped in a band and felt feverish), VACCINATION SITE WARMTH (Arm turned purple at the injection site, itched, welt shaped in a band and felt feverish), VACCINATION SITE PRURITUS (Arm turned purple at the injection site, itched, welt shaped in a band and felt feverish) and VACCINATION SITE URTICARIA (Arm turned purple at the injection site, itched, welt shaped in a band and felt feverish) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product used was not provided by the reporter.
Subject received covid vaccine 12/29/20; normal symptoms of pain in injection site an slight headache after. 1/5/21 had no symptoms but on 1/6/21 had pain in left arm at injection site with redness. Symptoms continued and on 1/8/21 she noticed 2 ?hive? areas: one at injection site and one lower on the arm, warm to touch and slight pain discomfort. On 1/11/21 a nurse spoke with her and the areas were still noticeable and bothering her, and she was questioning receiving the second dose. The nurse sent her to the occ health doc for evaluation and they called me to ensure we (SAE) would be reporting it since we administered it.
From correspondence received on 11/06/01, it was reported that a 30 year old male patient received a Fluzone SV '01-'02 vaccination administered on 11/04/01. Reportedly, the patient developed a raised red area 3 inches across at the injection site. Patient was seen in clinic.
This case was reported by a physician to a sales representative and described the occurrence of injection site burning in an adult female patient who received a hepatitis b vaccine recombinant Engerix B. On an unspecified date, the patient received a dose of Engerix B (dose number and lot number not provided). The physician reported that the patient complained that the injection burns when being administered. The patient was seen at a physicians office. The outcome of the injection site burning was not provided.  The reporting physician considered the injection site burning to probably be related to vaccination with Engerix B.
Patient is noticing slowing of hand movement and other muscular coordination.  Patient's PCP has assessed the patient and is doing further work up and testing.  Patient's BP and cardiac exam was normal
Developed fever around 7:30 PM five 1/2 days after MMR and had febrile seizure at 1:27am.
vaccine rec'd 2/11, and 5 days ago there was a swollen area, warm to touch and red, if I tough it, it itches.
Information has been received from a registered nurse concerning a 5 year old male who was vaccinated intramuscularly with a dose of varicella virus vaccine live (Oka/Merck). On 21 December 2005, the patient developed breakthrough chickenpox. Unspecified medical attention was sought. The outcome was recovering. No further information was available. There was no product quality complaint. Additional information has been requested.
abdomen started cramping; woke up with "blood in her panties"; arm hurt real bad; hard to move her hand over her head; could not sleep on the left side; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm hurt real bad), MOBILITY DECREASED (hard to move her hand over her head), DISCOMFORT (could not sleep on the left side), ABDOMINAL PAIN (abdomen started cramping) and VAGINAL HAEMORRHAGE (woke up with "blood in her panties") in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination.     The patient's past medical history included Infertility (The patient was told she is infertile at 38 years.) and Absence of menstruation. Concomitant products included MORPHINE, ESTRADIOL, PROGESTERONE, MODAFINIL, MORPHINE SULFATE, PANTOPRAZOLE, LEVETIRACETAM (KEPPRA XR), ALUMINIUM HYDROXIDE, DICYCLOVERINE HYDROCHLORIDE, MAGNESIUM OXIDUM LEVE (DICYCLOMINE CO), LEVODOPA, CLONAZEPAM, ESCITALOPRAM OXALATE (LEXAPRO), NORTRIPTYLINE, LORAZEPAM, DONEPEZIL, ONDANSETRON and CAFFEINE, CHLORZOXAZONE, PARACETAMOL, THIAMINE DISULFIDE (SOMA [CAFFEINE;CHLORZOXAZONE;PARACETAMOL;THIAMINE DISULFIDE]) for an unknown indication.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, the patient experienced PAIN IN EXTREMITY (arm hurt real bad), MOBILITY DECREASED (hard to move her hand over her head) and DISCOMFORT (could not sleep on the left side). On 02-May-2021, the patient experienced ABDOMINAL PAIN (abdomen started cramping) and VAGINAL HAEMORRHAGE (woke up with "blood in her panties"). On 11-Apr-2021, PAIN IN EXTREMITY (arm hurt real bad) had resolved. At the time of the report, MOBILITY DECREASED (hard to move her hand over her head), DISCOMFORT (could not sleep on the left side), ABDOMINAL PAIN (abdomen started cramping) and VAGINAL HAEMORRHAGE (woke up with "blood in her panties") outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment was administered.
Information has been received from a licensed visiting nurse concerning a 74 yr old female pt who at the end of Sep or beginning of Oct 2004, was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot number 649694/0386P). The pt developed a 3 inch area below the injection site which was swollen, red and looked like cellulitis. Unspecified medical attention was sought. The pt was treated with unspecified antihistamines. Subsequently, the pt recovered. The nurse requested that a lot check be performed on lot 649694/0358P. It was reported that the pt's injection site swelling, erythema and cellulitis were considered other medical events (OMIC). The records of testing prior to release of this lot have been checked by quality assurance and found to be satisfactory. The lot complies with the standards and was released. The nurse also reported 4 additional pt's who developed injection site swelling, erythema and cellulitis post vaccination with pneumococcal 23v polysaccharide vaccine (WAES0410USa01622, 0401USA01623, 0410USA01624, 0410USA01625). Additional information has been requested.
Fever x 6 days, cough, hypoxia (O2 sat 90% RA), day of illness 3 given PRELONE, CEFUROXIME, albuterol.
ABOUT 3 MINUTES AFTER RECEIVING VACCINE, PT REPORTED LIP SWELLING, PT EVALUATED AND FOUND TO HAVE MODERATE EDEMA TO LIPS, SENSATION OF SWELLING TONGUE AND THROAT. PT ALSO NOTED TO BE BRADYCARDIC, PLACED ON MONITOR, AND PT WAS IN BIGEMINY WITH A HR OF 55, PT GIVEN BENADRYL IM, VS WERE STABLE, MODERATELY HYPERTENSIVE, WITH AN 02 SAT OF 100%, IV ESTABLISHED AND PATIENT MONITOR WHILE AWAITING PARAMEDIC RECUSE AMBULANCE. PT DID NOT WORSEN AND BIGEMINY RESOLVED. 12 L PM WERE UNREMARKABLE, NO EPI GIVEN EN ROUTE, PT TRANSPORTED TO EMERGENCY DEPARTMENT WITHOUT INCIDENT.
Information has been received from a registered nurse concerning a 4-year-old female who on 08-FEB-2002 was vaccinated SC in the left arm with a first 0.5mL dos eof Varivax (Lot # 635794/0582L). Concomitant therapy that day included a first 0.5mL dose of MMR II (Lot # 639621/0899L). Other therapy included: a second 0.5mL dose of MMR II (Lot # 646585/0852P) administered on 03-FEB-2005; a first, second, third, fourth, and fifth 0.5mL dose of Infanrix on 02-APR-2001 (Lot # 983a2), 05-JUN-2001 (Lot # DTPa997a2), 02-AUG-2001 (Lot # DTPa505a2), 10-JUL-2002 (Lot # DTaP552A2), and 03-FEB-2005 (Lot # DTPa639A2); first 0.5mL dose of hepatitis A virus vaccine inactivated (Lot # 648218/0858P) on 28-FEB-2005; a first, second, and third 0.5mL dose of hepatitis B virus (+) Hib conj vaccine on 02-APR-2001 (Lot # 636992/1968K), 05-JUN-2001 (Lot # 638842/1763K), and 10-JUL-2002 (Lot # 643051/0284M); a 0.25mL dose of Fluzone on 05-DEC-2003 (Lot # U1269AA), 08-JAN-2004 (Lot # U1133AA), and 16-NOV-2004 (Lot # U1515AA); a first, second, third, and fourth 0.5mL dose of IPOL on 02-APR-2001 (Lot # R0516), 05-JUN-2001 (Lot # T0563), 10-JUL-2002 (Lot # UO422), and 03-FEB-2005 (Lot # W07501); and a first and second 0.5mL dose of Prevnar on 02-APR-2001 (Lot # 472046) and 02-AUG-2001 (Lot # 479-298). On 14-JAN-2006 the patient experienced breakthrough chickenpox disease. Subsequently, the patient recovered. No additional information is expected.
Systemic: Dizziness / Lightheadness-Mild, Systemic: Seizure-Mild, Additional Details: patient had a history of seizure not related to vaccination.
Her skin feels burned; A raised welt that itches; A raised welt; He arm reaction is the same as her penicillin response; The rash is moving to the underside of her arm; Her upper arm looked like a ham; Just over 2 hours she couldn't feel the weight of her body in the chair as if she were paralyzed; Over 2 hours after the shot she couldn't speak; This spontaneous case was reported by a consumer and describes the occurrence of DYSARTHRIA (Over 2 hours after the shot she couldn't speak), LIMB DISCOMFORT (Her upper arm looked like a ham), FEELING ABNORMAL (Just over 2 hours she couldn't feel the weight of her body in the chair as if she were paralyzed), SKIN BURNING SENSATION (Her skin feels burned) and PRURITUS (A raised welt that itches) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 052ED1A and 939676) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Penicillin allergy.   On 23-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Jul-2021, the patient experienced DYSARTHRIA (Over 2 hours after the shot she couldn't speak) and FEELING ABNORMAL (Just over 2 hours she couldn't feel the weight of her body in the chair as if she were paralyzed). On 24-Jul-2021, the patient experienced LIMB DISCOMFORT (Her upper arm looked like a ham), SKIN BURNING SENSATION (Her skin feels burned), PRURITUS (A raised welt that itches), URTICARIA (A raised welt), VACCINATION COMPLICATION (He arm reaction is the same as her penicillin response) and RASH (The rash is moving to the underside of her arm). At the time of the report, DYSARTHRIA (Over 2 hours after the shot she couldn't speak), LIMB DISCOMFORT (Her upper arm looked like a ham), FEELING ABNORMAL (Just over 2 hours she couldn't feel the weight of her body in the chair as if she were paralyzed), SKIN BURNING SENSATION (Her skin feels burned), PRURITUS (A raised welt that itches), URTICARIA (A raised welt), VACCINATION COMPLICATION (He arm reaction is the same as her penicillin response) and RASH (The rash is moving to the underside of her arm) outcome was unknown. Not Provided          Relevant concomitant medications were not reported by reporter Treatment information was not reported by reporter   Most recent FOLLOW-UP information incorporated above includes: On 31-Aug-2021: Additional information received on 31-08-2021 contains no new information.